[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-333957-105":59,"doc-detail-333957-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-clinicopathological-and-prognostic-significance-of-psmd14-in-cancers-based-on-bioinformatics-and-meta-analysis","The clinicopathological and prognostic significance of PSMD14 in cancers based on bioinformatics and meta-analysis","","Aim: To evaluate clinicopathological features and prognostic value of PSMD14 in cancers. Materials and methods: Literature was collected from public databases up to 22 June 2023 to analyze survival rates and clinicopathological characteristics associated with PSMD14; TCGA and GEO datasets were also used for validation. Results: Eight reports covering seven tumor types showed high PSMD14 expression correlates with worse overall survival and disease-free survival, and with larger tumor size, poorer differentiation, metastasis, and differing chemotherapy responses. Conclusion: PSMD14 may serve as a biomarker of poor prognosis in multiple cancers, including lung cancer, head and neck squamous cell carcinoma, ovarian cancer, breast cancer, and hepatocellular carcinoma.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-clinicopathological-and-prognostic-significance-of-psmd14-in-cancers-based-on-bioinformatics-and-meta-analysis/333957/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-clinicopathological-and-prognostic-significance-of-psmd14-in-cancers-based-on-bioinformatics-and-meta-analysis/333957.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of evaluating PSMD14 in cancers?","Question",{"text":112,"@type":113},"The study aims to assess clinicopathological characteristics and determine the prognostic value of PSMD14 expression in cancer patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the evidence collected and validated in the meta-analysis?",{"text":117,"@type":113},"Relevant literature was gathered from public databases up to 22 June 2023, and survival and clinicopathological data were analyzed; TCGA and GEO data were also used for validation.",{"name":119,"@type":110,"acceptedAnswer":120},"What does high PSMD14 expression indicate for patient outcomes?",{"text":121,"@type":113},"High PSMD14 expression is linked to poorer overall survival and disease-free survival, and it correlates with more aggressive clinicopathological features such as larger tumor size, differentiation changes, and metastasis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},333957,1790182057,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","META-ANALYSIS     \nThe clinicopathological and prognostic signiﬁcance of PSMD14 in cancers based on bioinformatics and meta-analysis  \nShu-Yi Donga, b, Shuxin Dinga, b, Zhen Menga, b and Bo Zou* , a, b  \na Department of Oral & Maxillofacial Surgery, Liaocheng People’s Hospital, Medical College of Liaocheng University, Liaocheng, Shandong, P. R. China; b Key Laboratory of Oral Maxillofacial-Head & Neck medical biology of Shandong Province, Liaocheng People’s Hospital, Liaocheng, Shandong, P. R. China  \nABSTRACT  \nAim: To evaluate the clinic-pathological features and prognostic value regarding PSMD14 in cancers. Materials & methods: Literature was gathered from public databases until 22 June 2023 to analyze data on survival rates and clinicopathological characteristics associated with PSMD14. TCGA and GEO data were also utilized for validation.  \nResults: Eight reports on seven types of tumors showed that high PSMD14 expression was linked to poorer overall survival and disease-free survival. PSMD14 expression also correlated with larger tumor size, differentiation and metastasis, as well as the effectiveness of various chemotherapy drugs.  \nConclusion: PSMD14 could serve as a potential biomarker of poor prognosis in cancers, including lung cancer, head and neck squamous cell carcinoma, ovarian cancer, breast cancer and hepatocellular carcinoma.  \nPLAIN LANGUAGE SUMMARY  \nCancer is harmful to human health. We need to find a marker that can help us identify and treat cancer. PSMD14 is one such marker. The expression of PSMD14 is higher in cancer tissues than in normal tissues. The expression of PSMD14 is associated with the sensitivity of cancer to anticancer drugs. Cancers with high PSMD14 expression tend to be more severe. Cancers with low expression of PSMD14 tend to have a longer survival time.  \nARTICLE HISTORY  \nReceived 26 November 2023 Accepted 16 September 2024  \nKEYWORDS  \nbioinformatical analysis; cancer; meta-analysis; PSMD14  \n1. Introduction  \nThe incidence of cancers is rising in both developed and developing countries with high rate of mortality, seriously impairing the quality of life of patients [1] . Although systemic treatments for cancers, such as chemotherapies and molecular-targeted therapies have made significant progress, the 5-year survival rate is still low due to distant metastasis and recurrence [2] . In addition, a large number of risk factors are associated with the occurrence and progression of tumors [3,4]. Therefore, it is of critical importance for the in-depth understanding of cancer prognostic markers and the discovery of effective  \ntherapeutic targets to improve patient-survival rates.  \nPSMD14 (also known as RPN11 or POH 1) is anon-ATPase regulatory subunit in the 26S proteasome which is one of the 19 fundamental subunits of a complete assembled 19S proteasome complex, belongs to the JAB1/MPN+/MOV34 (JAMM) domain protease family of deubiquitinating enzymes(DUBs) [5–7] . Studies  \nsuggested that PSMD14 may contribute to proteolytic degradation by the proteasome, and may also increase the stability of various ubiquitination substrates [8–10] . PSMD14 is a deubiquitinating enzyme which is associated with a variety of biological processes involved in UPS (ubiquitin proteasome system), such as cellular viability, transcriptional regulation and differentiation [11, 12] . PSMD14 was overexpressed in a variety of tumors, such as ovarian cancer tissues [13], lung cancer tissues [14], head and neck squamous cell carcinoma tissues [15, 16], breast cancer tissues [17], hepatocellular carcinoma tissues [11, 18], colorectal cancer tissues [18], bladder cancer tissues [19] . Some studies have pointed that the expression of PSMD14 is related to poor prognosis [8, 11, 15– 17], while others have reported the opposite [16, 18] . Therefore, the prognostic value of PSMD14 needs to be further defined.  \nWe hypothesized that higher expression of PSMD14 would lead to poor prognosis in cancers. In this study, bioinf","cbCaid108fDVUscP","https://ap.wps.com/l/cbCaid108fDVUscP","pdf",1386202,11,"English","# Introduction\n## PSMD14 background and rationale\n# Materials & methods\n## Search strategy\n# Results\n## Survival association and clinicopathological correlations\n# Conclusion\n## Prognostic biomarker implications\n# Plain language summary\n## Clinical meaning of PSMD14 expression","[{\"question\":\"What is the purpose of evaluating PSMD14 in cancers?\",\"answer\":\"The study aims to assess clinicopathological characteristics and determine the prognostic value of PSMD14 expression in cancer patients.\"},{\"question\":\"How was the evidence collected and validated in the meta-analysis?\",\"answer\":\"Relevant literature was gathered from public databases up to 22 June 2023, and survival and clinicopathological data were analyzed; TCGA and GEO data were also used for validation.\"},{\"question\":\"What does high PSMD14 expression indicate for patient outcomes?\",\"answer\":\"High PSMD14 expression is linked to poorer overall survival and disease-free survival, and it correlates with more aggressive clinicopathological features such as larger tumor size, differentiation changes, and metastasis.\"}]","The clinicopathological and prognostic significance of PSMD14 in cancers based on bioinformatics and meta-analysis | PDF",1790004761,28]